Prediction of radiation-induced hypothyroidism using radiomic data analysis does not show superiority over standard normal tissue complication models - Smyczynska, Urszula; Grabia, Szymon; Nowicka, Zuzanna; Papis-Ubych, Anna; Bibik, Robert; Latusek, Tomasz; Rutkowski, Tomasz; Fijuth, Jacek; Fendler, Wojciech; Tomasik, Bartłomiej (medRxiv, 2021)
State-of-art normal tissue complication probability (NTCP) models do not take into account more complex individual anatomical variations, which can be objectively quantitated and compared in radiomic analysis. The goal of this project was development of radiomic NTCP model for radiation-induced hypothyroidism (RIHT) using imaging biomarkers (radiomics). We gathered CT images and clinical data from 98 patients, who underwent intensity-modulated radiation therapy (IMRT) for head and neck cancers with a planned total dose of 70.0 Gy (33–35 fractions). During the 28-month (median) follow-up 27 patients (28%) developed RIHT. For each patient, we extracted 1316 radiomic features from original and transformed images using manually contoured thyroid masks. Creating models based on clinical, radiomic features or a combination thereof, we considered 3 variants of data preprocessing. Based on their performance metrics (sensitivity, specificity), we picked best models for each variant ((0.8, 0.96), (0.9, 0.93), (0.9, 0.89) variant-wise) and compared them with external NTCP models ((0.82, 0.88), (0.82, 0.88), (0.76, 0.91)). Our models reach accuracy comparable with or better than previously presented non-radiomic NTCP models. The benefit of our approach is obtaining the RIHT predictions before treatment planning to adjust IMRT plan to avoid the thyroid region in most susceptible patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Bioethics Committee of the Medical University of Lodz (KE/7/10, RNN/65/18).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Bioethics Committee of the Medical University of Lodz (KE/7/10, RNN/65/18).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw, anonymized clinical data and values of calculated radiomic features were included in supplementary material.AUCarea under curveCTcomputed tomographyFDRalse discovery rateGLCMgray level cooccurrence matrixGLDMgray level dependence matrixGLRLMgray level run length matrixGLSZMgray level size zone matrixGPCGaussian process classifierHNGhead and neck cancerICCinter-class correlation coefficientIMRTintensity-modulated radiation therapyMLPmultilayer perceptronNGTDMneighborhood gray tone difference matrixNTCPnormal tissue complication probabilityOARorgan at riskOPCoropharyngeal cancerPACSpicture archiving and communication systemROIregion of interestRTradiation therapyRIHTradiation-induced hypothyroidism